Erratum: Regulation of p53: Intricate loops and delicate balances (Biochem. Pharmacol. (2002) 64 (865-871) DOI: 10.1016/S0006-2952(02)01149-8);Regulation of p53: Intricate loops and delicate balances

Biochemical Pharmacology

Volumn 64, Issue 5-6, 2002, Pages 865-871

  Oren, Moshe ^a   Damalas, Alexander ^a   Gottlieb, Tanya ^a   Michael, Dan ^a   Taplick, Jan ^a   Leal, Juan Fernando Martinez ^a   Maya, Ruth ^a   Moas, Miri ^a   Seger, Rony ^a   Taya, Yoichi ^b   Ben Ze'ev, Avri ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Akt; Apoptosis; ARF; Beta catenin; Mdm2; p53; Ubiquitination

Indexed keywords

BETA CATENIN; PROTEIN KINASE B; PROTEIN MDM2; PROTEIN P53;

ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CELL FATE; HUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN INTERACTION;

EID: 0036710675     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2015.07.001     Document Type: Erratum

References (33)

1. Bargonetti J., Manfredi J.J. Multiple roles of the tumor suppressor p53. Curr. Opin. Oncol. 14:2002;86-91.
2. Michael D., Oren M. The p53 and Mdm2 families in cancer. Curr. Opin. Genet. Dev. 12:2002;53-59.
3. Pluquet O., Hainaut P. Genotoxic and non-genotoxic pathways of p53 induction. Cancer Lett. 174:2001;1-15.
4. Ryan K.M., Phillips A.C., Vousden K.H. Regulation and function of the p53 tumor suppressor protein. Curr. Opin. Cell. Biol. 13:2001;332-337.
5. Wahl G.M., Carr A.M. The evolution of diverse biological responses to DNA damage: insights from yeast and p53. Nat. Cell. Biol. 3:2001;E277-E286.
6. Woods D.B., Vousden K.H. Regulation of p53 function. Exp. Cell. Res. 264:2001;56-66.
7. Vogelstein B., Lane D., Levine A.J. Surfing the p53 network. Nature. 408:2000;307-310.
8. Lowe S.W. Activation of p53 by oncogenes. Endocr. Relat. Cancer. 6:1999;45-48.
9. Sherr C.J., Weber J.D. The ARF/p53 pathway. Curr. Opin. Genet. Dev. 10:2000;94-99.
10. Polakis P. Wnt signaling and cancer. Genes Dev. 14:2000;1837-1851.
11. Peifer M., Polakis P. Wnt signaling in oncogenesis and embryogenesis - a look outside the nucleus. Science. 287:2000;1606-1609.
12. Roose J., Clevers H. TCF transcription factors: molecular switches in carcinogenesis. Biochim. Biophys. Acta. 1424:1999;M23-M37.
13. Damalas A., Ben-Ze'ev A., Simcha I., Shtutman M., Leal J.F., Zhurinsky J., Geiger B., Oren M. Excess beta-catenin promotes accumulation of transcriptionally active p53. EMBO J. 18:1999;3054-3063.
14. Damalas A., Kahan S., Shtutman M., Ben-Ze'ev A., Oren M. Deregulated beta-catenin induces a p53- and ARF-dependent growth arrest and cooperates with Ras in transformation. EMBO J. 20:2001;4912-4922.
15. Kinzler K.W., Vogelstein B. Lessons from hereditary colorectal cancer. Cell. 87:1996;159-170.
16. Esteller M., Tortola S., Toyota M., Capella G., Peinado M.A., Baylin S.B., Herman J.G. Hypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status. Cancer Res. 60:2000;129-133.
17. Fodde R., Kuipers J., Rosenberg C., Smits R., Kielman M., Gaspar C., van Es J.H., Breukel C., Wiegant J., Giles R.H., Clevers H. Mutations in the APC tumour suppressor gene cause chromosomal instability. Nat. Cell. Biol. 3:2001;433-438.
18. Sadot E., Geiger B., Oren M., Ben-Ze'ev A. Down-regulation of beta-catenin by activated p53. Mol. Cell. Biol. 21:2001;6768-6781.
19. Matsuzawa S.I., Reed J.C., Siah-l S.I.P. Ebi collaborate in a novel pathway for beta-catenin degradation linked to p53 responses. Mol. Cell. 7:2001;915-926.
20. Liu J., Stevens J., Rote C.A., Yost H.J., Hu Y., Neufeld K.L., White R.L., Matsunami N. Siah-1 mediates a novel beta-catenin degradation pathway linking p53 to the adenomatous polyposis coli protein. Mol. Cell. 7:2001;927-936.
21. Sigal A., Rotter V. Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome. Cancer Res. 60:2000;6788-6793.
22. Su F., Overholtzer M., Besser D., Levine A.J. WISP-1 attenuates p53-mediated apoptosis in response to DNA damage through activation of the Akt kinase. Genes Dev. 16:2002;46-57.
23. Ries S., Biederer C., Woods D., Shifman O., Shirasawa S., Sasazuki T., McMahon M., Oren M., McCormick F. Opposing effects of Ras on p53: transcriptional activation of mdm2 and induction of p19ARF. Cell. 103:2000;321-330.
24. Datta S.R., Brunet A., Greenberg M.E. Cellular survival: a play in three Akts. Genes Dev. 13:1999;2905-2927.
25. Gottlieb TM, Leal JFM, Seger R, Taya Y and Oren M, Cross-talk between Akt, p53 and Mdm2: Possible implications for regulation of apoptosis. Oncogene 2002;21:1299-303.
26. Mayo L.D., Donner D.B. A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus. Proc. Natl. Acad. Sci. U.S.A. 98:2001;11598-11603.
27. Zhou B.P., Liao Y., Xia W., Zou Y., Spohn B., Hung M.C. HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation. Nat. Cell. Biol. 3:2001;973-982.
28. Sabbatini P., McCormick F. Phosphoinositide 3-OH kinase (PI3K) and PKB/Akt delay the onset of p53-mediated, transcriptionally dependent apoptosis. J. Biol. Chem. 274:1999;24263-24269.
29. Gottlieb E., Oren M. p53 facilitates pRb cleavage in IL-3-deprived cells: novel pro-apoptotic activity of p53 [in process citation]. EMBO J. 17:1998;3587-3596.
30. Simpson L., Parsons R. PTEN: life as a tumor suppressor. Exp. Cell. Res. 264:2001;29-41.
31. Stambolic V., MacPherson D., Sas D., Lin Y., Snow B., Jang Y., Benchimol S., Mak T.W. Regulation of PTEN transcription by p53. Mol. Cell. 8:2001;317-325.
32. Mayo LD, Dixon JE, Durden DL, Tonks NK, Donner DB. PTEN protects p53 from Mdm2 and sensitizes cancer cells to chemotherapy. J Biol Chem 2002;277:5484-9.
33. Fang L., Li G., Liu G., Lee S.W., Aaronson S.A. p53 induction of heparin-binding EGF-like growth factor counteracts p53 growth suppression through activation of MAPK and PI3K/Akt signaling cascades. EMBO J. 20:2001;1931-1939.